Filings
Finds words inside filing documents. Searching Evommune, Inc.'s filings · 41 documents indexed.
2 documents · 12 matches
-
EVMN Evommune, Inc. 10-K 2026-03-05
Item 1A. Risk Factors.
tariffs could result in increased research and development expenses, including with respect to increased costs associated with active pharmaceutical ingredients6 matches in this document -
EVMN Evommune, Inc. 10-Q 2025-12-11
Item 1A. Risk Factors.
tariffs could result in increased research and development expenses, including with respect to increased costs associated with active pharmaceutical ingredients6 matches in this document
Page 1 of 1 · 2 documents